Koshikawa S - Search Results

1

Effect of recombinant human erythropoietin on the anemia of chronic renal failure.

Urabe A, Takaku F, Mizoguchi H, Kubo K, Ota K, Shimizu N, Tanaka K, Mimura N, Nihei H, Koshikawa S, et al. Urabe A, et al. Among authors: koshikawa s. Int J Cell Cloning. 1988 May;6(3):179-91. doi: 10.1002/stem.5530060304. Int J Cell Cloning. 1988. PMID: 3397592 Free article.

2

Clinical effect of recombinant human erythropoietin on anemia associated with chronic renal failure. A multi-institutional study in Japan.

Akizawa T, Koshikawa S, Takaku F, Urabe A, Akiyama N, Mimura N, Otsubo O, Nihei H, Suzuki Y, Kawaguchi Y, et al. Akizawa T, et al. Among authors: koshikawa s. Int J Artif Organs. 1988 Sep;11(5):343-50. Int J Artif Organs. 1988. PMID: 3056862 Clinical Trial.

3

A multicenter study with once a week or once every two weeks high-dose subcutaneous administration of recombinant human erythropoietin in continuous ambulatory peritoneal dialysis.

Nomoto Y, Kawaguchi Y, Kubota M, Tagawa H, Kubo K, Ogura Y, Shoji T, Kawada Y, Koshikawa S, Mimura N, et al. Nomoto Y, et al. Among authors: koshikawa s. Perit Dial Int. 1994;14(1):56-60. Perit Dial Int. 1994. PMID: 8312416 Clinical Trial.

4

Changes in endocrinological functions in hemodialysis patients associated with improvements in anemia after recombinant human erythropoietin therapy.

Akizawa T, Kinugasa E, Nakayama F, Takahashi T, Koshikawa S, Shimizu N. Akizawa T, et al. Among authors: koshikawa s. Contrib Nephrol. 1990;82:86-93. doi: 10.1159/000418722. Contrib Nephrol. 1990. PMID: 2093532 No abstract available.

5

Current status of renal replacement therapy in Japan.

Teraoka S, Toma H, Nihei H, Ota K, Babazono T, Ishikawa I, Shinoda A, Maeda K, Koshikawa S, Takahashi T, et al. Teraoka S, et al. Among authors: koshikawa s. Am J Kidney Dis. 1995 Jan;25(1):151-64. doi: 10.1016/0272-6386(95)90640-1. Am J Kidney Dis. 1995. PMID: 7810520

6

Nafamostat mesilate: a regional anticoagulant for hemodialysis in patients at high risk for bleeding.

Akizawa T, Koshikawa S, Ota K, Kazama M, Mimura N, Hirasawa Y. Akizawa T, et al. Among authors: koshikawa s. Nephron. 1993;64(3):376-81. doi: 10.1159/000187357. Nephron. 1993. PMID: 8341382

7

Clinical application of Fragmin (FR-860) in hemodialysis: multicenter cooperative study in Japan.

Suzuki T, Ota K, Naganuma S, Koshikawa S, Hirasawa Y, Nakagawa S, Otsubo O, Akizawa T. Suzuki T, et al. Among authors: koshikawa s. Semin Thromb Hemost. 1990 Oct;16 Suppl:46-54. Semin Thromb Hemost. 1990. PMID: 1962904 Clinical Trial.

8

Effects of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patients.

Akizawa T, Kinugasa E, Kitaoka T, Koshikawa S. Akizawa T, et al. Among authors: koshikawa s. Nephron. 1991;58(4):400-6. doi: 10.1159/000186470. Nephron. 1991. PMID: 1922603

9

Comparative clinical trial of regional anticoagulation for hemodialysis.

Akizawa T, Kitaoka T, Sato M, Koshikawa S, Hirasawa Y, Kazama M, Mimura N, Ota K. Akizawa T, et al. Among authors: koshikawa s. ASAIO Trans. 1988 Jul-Sep;34(3):176-8. ASAIO Trans. 1988. PMID: 3058171 Clinical Trial.

10

Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients.

Takayama K, Nagai T, Kinugasa E, Akizawa T, Koshikawa S. Takayama K, et al. Among authors: koshikawa s. ASAIO Trans. 1991 Jul-Sep;37(3):M187-8. ASAIO Trans. 1991. PMID: 1836334

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters